| [1] |
Arase Y,Kobayashi M,Suzuki F,et al.Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.Hepatology,2013; 57: 964-973.
|
| [2] |
中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版).中华肝脏病杂志,2011,19: 13-24.
|
| [3] |
中华人民共和国卫生部,原发性肝癌诊疗规范(2011年版).临床肿瘤学杂志,2011,16: 929-946.
|
| [4] |
Bruix J,Sherman M.Management of hepatocellular carcinoma:an update.Hapetology,2011,53: 1020-1022.
|
| [5] |
Kengvw,Largaespadada,Billanuevaa.Why men are at higher risk for hepatocellular carcinoma.J Hepatol,2012,57:453-454.
|
| [6] |
Hosaka T,Suzuke F,Kobayashi M,et al.Long-term entecavir treatment reduces hepatlcellular carcinoma incidence in patients with hepatitis B virus infection.Hepatology,2013,58: 98-107.
|
| [7] |
Xiao L,Zhou B,Gao H,et al.Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure. J Medical Virol,2011,83:1544-1550.
|
| [8] |
杨创国,于乐龙,陈金军,等.688例慢性乙型肝炎中HBeAg阴性和阳性患者临床和病毒特点比较分析.中华内科杂志,2005,44: 648-651.
|
| [9] |
裴彦祯,韩涛,马晓艳,等.HBsAg及HBV DNA定量水平在慢性乙型肝炎、肝硬化和肝癌患者中的变化,中华肝脏病杂志,2011,10:743-746.
|
| [10] |
Chen QY, Harrison TJ, Sabin CA, et al. The effect of HBV genotype C on the development of HCC differs between wild-type viruses and those with BCP double mutations(T(1762)A(1764).Hepat Mon, 2014,14: 110-110.
|
